Osteokines in Nonalcoholic Fatty Liver Disease
Current Obesity Reports · 03.09.2024 · 13 (4) · 703-723
DOI: 10.1007/s13679-024-00586-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Obesity Reports, online erschienen am 03.09.2024. Verfasst von Ilias D Vachliotis und 3 weiteren Autor:innen. Beteiligte Einrichtung: First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. ivachliot@auth.gr. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Liver, Osteocalcin, Fibroblast Growth Factor-23. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 155 Literaturangaben.
Abstract (Originalsprache)
PURPOSE OF REVIEW: To critically summarize evidence on the potential role of osteokines in the pathogenesis and progression of nonalcoholic fatty liver disease (NAFLD). RECENT FINDINGS: There are emerging data supporting that certain osteokines, which are specific bone-derived proteins, may beneficially or adversely affect hepatic metabolism, and their alterations in the setting of osteoporosis or other bone metabolic diseases may possibly contribute to the development and progression of NAFLD. There is evidence showing a potential bidirectional association between NAFLD and bone metabolism, which may imply the existence of a liver-bone axis. In this regard, osteocalcin, osteoprotegerin, bone morphogenic protein 4 (BMP4) and BMP6 appear to have a positive impact on the liver, thus possibly alleviating NAFLD, whereas osteopontin, receptor activator of nuclear factor kappa Β ligand (RANKL), sclerostin, periostin, BMP8B, and fibroblast growth factor 23 (FGF23) appear to have a negative impact on the liver, thus possibly exacerbating NAFLD. The potential implication of osteokines in NAFLD warrants further animal and clinical research in the field that may possibly result in novel therapeutic targets for NAFLD in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. ivachliot@auth.gr.
- Department of Endocrinology, 424 General Military Training Hospital, Thessaloniki, Greece.
- Department of Clinical Radiology, AHEPA University Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. spolyzos@auth.gr.
Zitieren
APA
Vachliotis, I. D., Anastasilakis, A. D., Rafailidis, V., & Polyzos, S. A. (2024). Osteokines in Nonalcoholic Fatty Liver Disease. Current Obesity Reports, 13(4), 703-723. https://doi.org/10.1007/s13679-024-00586-9
Vancouver
Vachliotis ID, Anastasilakis AD, Rafailidis V, Polyzos SA. Osteokines in Nonalcoholic Fatty Liver Disease. Current Obesity Reports. 2024;13(4):703-723. doi:10.1007/s13679-024-00586-9
BibTeX
@article{Vachliotis2024,
author = {Vachliotis, Ilias D and Anastasilakis, Athanasios D and Rafailidis, Vasileios and Polyzos, Stergios A},
title = {Osteokines in Nonalcoholic Fatty Liver Disease},
journal = {Current Obesity Reports},
year = {2024},
volume = {13},
number = {4},
pages = {703--723},
doi = {10.1007/s13679-024-00586-9}
}
EUVIMED